MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2024$885,975
-16.5%
58,173
+3.5%
0.00%
Q1 2024$1,061,471
-1.4%
56,222
-0.2%
0.00%
Q4 2023$1,076,209
+3.1%
56,346
-3.1%
0.00%
Q3 2023$1,043,362
-14.9%
58,126
-3.7%
0.00%
Q2 2023$1,225,769
+8.8%
60,353
-2.3%
0.00%
Q1 2023$1,126,77661,7750.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$29,404,28419.15%
Decheng Capital Management III (Cayman), LLC 869,790$15,864,9706.40%
Octagon Capital Advisors LP 2,172,000$39,617,2805.70%
Boxer Capital, LLC 1,432,200$26,1231.28%
PFM Health Sciences, LP 1,559,947$28,453,4331.26%
SECTORAL ASSET MANAGEMENT INC 293,646$5,356,1031.03%
DAFNA Capital Management LLC 175,217$3,195,9580.96%
Ikarian Capital, LLC 230,000$4,195,2000.95%
Tejara Capital Ltd 50,000$912,0000.47%
Capital Impact Advisors, LLC 20,501$373,9380.46%
View complete list of ARCUS BIOSCIENCES INC shareholders